Beacon Investment Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.2M | Sell |
112,362
-2,394
| -2% | -$315K | 0.53% | 49 |
|
|
2026
Q1 | $16M | Buy |
114,756
+3,225
| +3% | +$452K | 0.66% | 46 |
|
|
2025
Q4 | $13.7M | Buy |
111,531
+10,449
| +10% | +$1.27M | 0.56% | 49 |
|
|
2025
Q3 | $11.2M | Buy |
101,082
+4,195
| +4% | +$477K | 0.47% | 56 |
|
|
2025
Q2 | $10.7M | Buy |
96,887
+10,226
| +12% | +$1.09M | 0.47% | 59 |
|
|
2025
Q1 | $9.71M | Buy |
86,661
+6,429
| +8% | +$663K | 0.45% | 63 |
|
|
2024
Q4 | $7.41M | Buy |
80,232
+3,637
| +5% | +$327K | 0.32% | 73 |
|
|
2024
Q3 | $6.42M | Buy |
76,595
+1,048
| +1% | +$80K | 0.27% | 79 |
|
|
2024
Q2 | $5.18M | Sell |
75,547
-317
| -0.4% | -$21.2K | 0.22% | 83 |
|
|
2024
Q1 | $5.56M | Buy |
75,864
+1,493
| +2% | +$115K | 0.24% | 81 |
|
|
2023
Q4 | $6.02M | Buy |
74,371
+923
| +1% | +$71.8K | 0.27% | 82 |
|
|
2023
Q3 | $5.5M | Sell |
73,448
-547
| -0.7% | -$42.1K | 0.27% | 79 |
|
|
2023
Q2 | $5.7M | Sell |
73,995
-384
| -0.5% | -$30.6K | 0.26% | 82 |
|
|
2023
Q1 | $6.17M | Buy |
74,379
+571
| +0.8% | +$47.3K | 0.3% | 76 |
|
|
2022
Q4 | $6.34M | Buy |
73,808
+892
| +1% | +$70.6K | 0.32% | 69 |
|
|
2022
Q3 | $4.5M | Sell |
72,916
-311
| -0.4% | -$19.6K | 0.25% | 81 |
|
|
2022
Q2 | $4.53M | Buy |
73,227
+563
| +0.8% | +$34.9K | 0.24% | 89 |
|
|
2022
Q1 | $4.32M | Buy |
72,664
+1,523
| +2% | +$97.4K | 0.18% | 96 |
|
|
2021
Q4 | $5.17M | Sell |
71,141
-129
| -0.2% | -$8.88K | 0.2% | 93 |
|
|
2021
Q3 | $4.98M | Sell |
71,270
-147
| -0.2% | -$10.3K | 0.21% | 90 |
|
|
2021
Q2 | $4.92M | Buy |
71,417
+6,327
| +10% | +$422K | 0.2% | 94 |
|
|
2021
Q1 | $4.21M | Buy |
65,090
+3,507
| +6% | +$226K | 0.18% | 97 |
|
|
2020
Q4 | $3.59M | Buy |
61,583
+3,834
| +7% | +$231K | 0.17% | 98 |
|
|
2020
Q3 | $3.65M | Buy |
57,749
+39,679
| +220% | +$2.75M | 0.19% | 91 |
|
|
2020
Q2 | $1.39M | Sell |
18,070
-2
| -0% | -$153 | 0.08% | 131 |
|
|
2020
Q1 | $1.35M | Buy |
18,072
+85
| +0.5% | +$5.87K | 0.1% | 123 |
|
|
2019
Q4 | $1.17M | Sell |
17,987
-710
| -4% | -$46.2K | 0.06% | 134 |
|
|
2019
Q3 | $1.19M | Sell |
18,697
-180
| -1% | -$11.8K | 0.12% | 109 |
|
|
2019
Q2 | $1.27M | Sell |
18,877
-15,302
| -45% | -$1.01M | 0.14% | 101 |
|
|
2019
Q1 | $2.22M | Sell |
34,179
-27,482
| -45% | -$1.83M | 0.24% | 88 |
|
|
2018
Q4 | $3.86M | Sell |
61,661
-4,856
| -7% | -$339K | 0.43% | 65 |
|
|
2018
Q3 | $5.14M | Sell |
66,517
-1,085
| -2% | -$81.9K | 0.5% | 58 |
|
|
2018
Q2 | $4.79M | Sell |
67,602
-7,671
| -10% | -$542K | 0.48% | 61 |
|
|
2018
Q1 | $5.67M | Buy |
75,273
+11,179
| +17% | +$889K | 0.59% | 53 |
|
|
2017
Q4 | $4.59M | Buy |
64,094
+434
| +0.7% | +$33K | 0.49% | 62 |
|
|
2017
Q3 | $5.16M | Buy |
63,660
+46,504
| +271% | +$3.56M | 0.44% | 66 |
|
|
2017
Q2 | $1.21M | Buy |
17,156
+344
| +2% | +$22.9K | 0.22% | 18 |
|
|
2017
Q1 | $1.14M | Buy |
16,812
+262
| +2% | +$18.4K | 0.22% | 17 |
|
|
2016
Q4 | $1.19M | Buy |
16,550
+51
| +0.3% | +$3.79K | 0.23% | 15 |
|
|
2016
Q3 | $1.3M | Sell |
16,499
-1,636,646
| -99% | -$133M | 0.29% | 11 |
|
|
2016
Q2 | $1.38M | Buy |
1,653,145
+1,636,698
| +9,951% | +$145M | 0.3% | 9 |
|
|
2016
Q1 | $1.51M | Sell |
16,447
-355
| -2% | -$32K | 0.32% | 7 |
|
|
2015
Q4 | $1.7M | Hold |
16,802
| – | – | 0.32% | 10 |
|
|
2015
Q3 | $1.65M | Hold |
16,802
| – | – | 0.3% | 11 |
|
|
2015
Q2 | $1.97M | Buy |
+16,802
| New | +$1.84M | 0.31% | 12 |
|
Other funds holding GILD
CIM
CGH
CNB
AP
P
QCM
Beacon Investment Advisory Services's GILD Position: Q2 2026 in Review
Beacon Investment Advisory Services reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $315K and leaving 112,362 shares worth $14.2M. The position accounts for 0.53% of the portfolio, ranked #49.
Beacon Investment Advisory Services first reported a position in GILD in Q2 2015 and has held it in 45 quarters since. The position peaked at $16M in Q1 2026. 333 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Beacon Investment Advisory Services held 112,362 shares of Gilead Sciences worth $14.2M as of Q2 2026.
- Beacon Investment Advisory Services sold 2,394 Gilead Sciences shares in Q2 2026, an estimated $315K.
- Gilead Sciences made up 0.53% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #49 holding.
- Beacon Investment Advisory Services first reported a position in Gilead Sciences in Q2 2015 and has held it in 45 quarters since.
- Beacon Investment Advisory Services's Gilead Sciences position peaked at $16M in Q1 2026.
- 333 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.